With increasing use of real-world data (RWD) throughout the drug development cycle - from initial discovery through to market approval and post-market monitoring - comes increasing scrutiny about the quality of the data. This episode of tHEORetically Speaking features Jeff Brown, PhD and Matvey Palchuk, MD, MS, FAMIA of TriNetX, who discuss the rise of RWD and its role in revolutionizing healthcare research, and how the TriNetX team approaches data quality to ensure research-ready RWD.